Toggle navigation
Home
Search
Services
Blog
Contact
About
New Therapy for Ocular Herpes Simplex Keratitis
Burger, Richard M.
Redox Pharmaceutical Corporation, Greenvale, NY, United States
Search 21 grants from Richard Burger
Search grants from Redox Pharmaceutical Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Development of an ophthalmic diagnostic probe for neurodegenerativedisorders
Manual Control of the Upper Esophageal Sphincter
Population-Based Autism Genetics &Environment Study
The Role of Glutamate in the Physiological Development of Dendritic Spines
Hormonal Control of Social Behavior
Recently added grants:
Alcohol Use Phenotypes and Posttraumatic Stress Disorder: Investigating Shared Genetic, Behavioral, and Psychophysiological Risk Factors
Modifiable cardiovascular factors linking type 2 diabetes and Alzheimer's disease
Investigating the pro-aging role of B2M and MHC molecules on regenerative and cognitive function in the brain
Clinical Features and Neuropathological Basis of Sleep Wake Behavior in Alzheimer's and PSP
A platform for cell type-level transcriptomic, epigenomic and spatial interrogation of Alzheimer's disease
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44EY011724-03
Application #
2518778
Study Section
Special Emphasis Panel (ZRG1-SEN (02))
Project Start
1996-09-01
Project End
1999-08-31
Budget Start
1997-09-01
Budget End
1999-08-31
Support Year
3
Fiscal Year
1997
Total Cost
Indirect Cost
Institution
Name
Redox Pharmaceutical Corporation
Department
Type
DUNS #
City
Greenvale
State
NY
Country
United States
Zip Code
11548
Related projects
NIH 1997
R44 EY
New Therapy for Ocular Herpes Simplex Keratitis
Burger, Richard M. / Redox Pharmaceutical Corporation
NIH 1996
R44 EY
New Therapy for Ocular Herpes Simplex Keratitis
Burger, Richard M. / Redox Pharmaceutical Corporation
Publications
Asbell, P A; Epstein, S P; Wallace, J A et al.
(1998)
Efficacy of cobalt chelates in the rabbit eye model for epithelial herpetic keratitis.
Cornea 17:550-7
Comments
Be the first to comment on Richard Burger's grant